☆ 4.1 Article

The cost-of-illness and burden-of-disease of treatment-resistant depression in Austria

JOURNAL OF MEDICAL ECONOMICS (2023)

Related references

Note: Only part of the references are listed.

Article Economics

Real-World Treatment Patterns, Outcomes, Resource Utilization and Costs in Treatment-Resistant Major Depressive Disorder: PATTERN, a Retrospective Cohort Study in Belgium

B. Gillain et al.

Summary: Treatment-resistant depression (TRD) poses a significant economic burden and unmet need for patients and society, with the highest costs driven by absenteeism in the moderate to severe major depressive episode (MDE) state. The study in Belgium examined treatment patterns, outcomes, resource utilization, and costs in managing TRD by psychiatrists, shedding light on the challenges and costs associated with this condition.

PHARMACOECONOMICS-OPEN (2022)

Add to Collection

Article Health Care Sciences & Services

The costs of treatment resistant depression: evidence from a survey among Italian patients

Matteo Ruggeri et al.

Summary: The study estimated the cost of Treatment Resistant Depression (TRD) in Italy by analyzing the healthcare and social costs, as well as out of pocket expenditure (OOPE) of TRD patients. The average healthcare costs were found to be €2,653 per patient, with a total cost of €7,140 including lost working days. The study also highlighted the impact of regional differences on the amount of OOPE for TRD.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Treatment-resistant depression and major depression with suicide risk-The cost of illness and burden of disease

Rute Dinis Sousa et al.

Summary: Treatment-Resistant Depression and Major Depression with Suicide Risk have significant impacts on both the health of the population and the economy in Portugal. This study estimated the burden of disease and costs associated with these two types of depression, and found that they impose substantial productivity costs on the Portuguese economy and society.

FRONTIERS IN PUBLIC HEALTH (2022)

Add to Collection

Article Clinical Neurology

Economic impact of treatment-resistant depression: A retrospective observational study

Victor Perez-Sola et al.

Summary: The study in Spain aimed to determine the incidence of Treatment-Resistant Depression (TRD) and estimate its economic burden using real world data. Results showed that TRD patients had higher costs and resource use compared to non-TRD patients, with a 3-year cumulative incidence of 16.5% among MDD patients.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Add to Collection

Article Economics

The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder

Alix Arnaud et al.

Summary: This retrospective cohort study aimed to determine the economic burden among patients with major depressive disorder (MDD) and found that there was an increased economic burden associated with delay of episode resolution as early as the second line of treatment compared to the first line.

PHARMACOECONOMICS (2021)

Add to Collection

Review Surgery

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA 2020 statement, an updated version of the 2009 statement, includes new reporting guidance that reflects advances in research methods. This article introduces the PRISMA 2020 27-item checklist and related information.

INTERNATIONAL JOURNAL OF SURGERY (2021)

Add to Collection

Article Psychology, Clinical

The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States

Maryia Zhdanava et al.

Summary: This study evaluated the prevalence and burden of treatment-resistant depression (TRD) in the United States, finding that TRD accounted for a significant proportion of the burden of medication-treated major depressive disorder (MDD). The study highlighted the disproportionate health care costs and unemployment associated with TRD, suggesting potential economic and societal gains with effective management.

JOURNAL OF CLINICAL PSYCHIATRY (2021)

Add to Collection

Article Economics

PMH20 Healthcare Utilization in Patients with Treatment-Resistant Depression (TRD) in Austria

M. Traunfellner

VALUE IN HEALTH (2020)

Add to Collection

Article Economics

A general framework for classifying costing methods for economic evaluation of health care

Zuzana Spacirova et al.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2020)

Add to Collection

Meeting Abstract Clinical Neurology

Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls

K. Koehler-Forsberg et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)

Add to Collection

Review Clinical Neurology

Management of Treatment-Resistant Depression: Challenges and Strategies

Daphne Voineskos et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)

Add to Collection

Article Psychiatry

The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study

Dena H. Jaffe et al.

BMC PSYCHIATRY (2019)

Add to Collection

Review Clinical Neurology

Treatment-resistant depression and suicidality

Isidoor O. Bergfeld et al.

JOURNAL OF AFFECTIVE DISORDERS (2018)

Add to Collection

Article Psychology, Clinical

Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database

Tony B. Amos et al.

JOURNAL OF CLINICAL PSYCHIATRY (2018)

Add to Collection

Article Psychology, Clinical

The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)

Paul E. Greenberg et al.

JOURNAL OF CLINICAL PSYCHIATRY (2015)

Add to Collection

Article Public, Environmental & Occupational Health

Disability weights for the Global Burden of Disease 2013 study

Joshua A. Salomon et al.

LANCET GLOBAL HEALTH (2015)

Add to Collection

Article Psychiatry

Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up

W. W. IsHak et al.

ACTA PSYCHIATRICA SCANDINAVICA (2015)

Add to Collection

Article Medicine, General & Internal

Chronic and Treatment Resistant Depression

Tom Bschor et al.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2014)

Add to Collection

Review Health Policy & Services

A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996-2013

David A. Mrazek et al.

PSYCHIATRIC SERVICES (2014)

Add to Collection

Review Gastroenterology & Hepatology

Cost-of-illness studies: concepts, scopes, and methods

Changik Jo

CLINICAL AND MOLECULAR HEPATOLOGY (2014)

Add to Collection

Article Pharmacology & Pharmacy

The Economic Burden of Treatment-Resistant Depression

Natalia Olchanski et al.

CLINICAL THERAPEUTICS (2013)

Add to Collection

Article Clinical Neurology

Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program

A. Konstantinidis et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)

Add to Collection

Article Clinical Neurology

The size and burden of mental disorders and other disorders of the brain in Europe 2010

H. U. Wittchen et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)

Add to Collection

Article Medicine, General & Internal

Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder

Jasmina I. Ivanova et al.

CURRENT MEDICAL RESEARCH AND OPINION (2010)

Add to Collection

Article Economics

Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report

Michael Drummond et al.

VALUE IN HEALTH (2009)

Add to Collection

Article Medicine, General & Internal

The STAR*D study: Treating depression in the real world

Bradley N. Gaynes et al.

CLEVELAND CLINIC JOURNAL OF MEDICINE (2008)

Add to Collection

Article Medicine, General & Internal

Guidelines for health-economic evaluations in Austria

Evelyn Walter et al.

WIENER MEDIZINISCHE WOCHENSCHRIFT (2006)

Add to Collection

Article Health Care Sciences & Services

The PHQ-9 - Validity of a brief depression severity measure

K Kroenke et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.